astria therapeutics glp-1 receptor agonist weight management diabetes treatments Advances in agonists delivery systems for obesity and GLP-1 for Diabetes vs GLP-1
Description
The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease
Chen WM, Ng HJ, Jao AT, Wu SY, Soong RS
Bastick, A
Preliminary research suggests it may influence incretin hormone pathways, though clinical evidence supporting meaningful GLP-1 or GIP enhancement in humans is lacking
